Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00900068 · ClinicalTrials.gov registry record
Blood Samples From Patients on a Clinical Trial to CINV During HSCT
A clinical trial, sponsored by OHSU Knight Cancer Institute.
- Terminated
- Registry status
- 9
- Enrollment target
NCT00900068: Clinical Trial study, sponsored by OHSU Knight Cancer Institute.
NCT00900068 is a clinical trial that was terminated before completion, run by OHSU Knight Cancer Institute. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00900068 was terminated before completion, sponsored by OHSU Knight Cancer Institute.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood in the laboratory from patients with cancer may help doctors learn more about nausea and vomiting caused by cancer treatment. PURPOSE: This laboratory study is looking at blood samples from patients with cancer who were treated on a clinical trial to control nausea and vomiting during donor stem cell transplant.
Interventions
- OTHER laboratory biomarker analysis
- OTHER medical chart review
- OTHER immunoenzyme technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-10 |
Why NCT00900068 stopped before completion
NCT00900068 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT00900068 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00900068 about?
NCT00900068 is a clinical study titled "Blood Samples From Patients on a Clinical Trial to CINV During HSCT". RATIONALE: Studying samples of blood in the laboratory from patients with cancer may help doctors learn more about nausea and vomiting caused by cancer treatment. PURPOSE: This laboratory study is looking at blood samples from patients with cancer who were treated on a clinical trial to control nau...
What is the current status of trial NCT00900068?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2008-08. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00900068?
The interventions under investigation include: laboratory biomarker analysis (OTHER), medical chart review (OTHER), immunoenzyme technique (OTHER).
Who is sponsoring clinical trial NCT00900068?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia